Davide Moiani Selected Research

Poly Adenosine Diphosphate Ribose

12/2019

Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Davide Moiani Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 12/2019
1	Genomic Instability 08/2021
1	Infections 01/2021
1	COVID-19 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 12/2019

Drug/Important Bio-Agent (IBA)

2	poly ADP-ribose glycohydrolaseIBA 01/2021 - 12/2019
1	Protein Tyrosine PhosphatasesIBA 01/2022
1	Vitamin E FDA LinkGeneric 01/2022
1	Biomarkers (Surrogate Marker)IBA 08/2021
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 08/2021
1	Floxuridine (FUdR)FDA LinkGeneric 01/2021
1	UracilIBA 01/2021
1	VaccinesIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	Glycoside Hydrolases (Endoglycosidases)IBA 01/2021
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Pemetrexed (MTA)FDA Link 01/2021
1	nedaplatinIBA 12/2019
1	Poly Adenosine Diphosphate RiboseIBA 12/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2019

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2021
1	Immunotherapy 01/2022